# PDT Study for Exudative AMD With PCV

> **NCT00331435** · PHASE4 · COMPLETED · sponsor: **Ophthalmic PDT Study Group** · enrollment: 113 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **PROCEDURE:** Ocular photodynamic therapy with verteporfin

## Key facts

- **NCT ID:** NCT00331435
- **Lead sponsor:** Ophthalmic PDT Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-01
- **Final completion:** 2010-01
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2011-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331435, "PDT Study for Exudative AMD With PCV". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00331435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*